Stephen Stamp

Stephen Stamp

Chief Executive Officer at BIODEXA PHARMACEUTICALS PLC

Net worth: - $ as of 30/05/2026

65 year
Health Technology
Commercial Services
Finance

Profile

Stephen Anthony Stamp is currently Chief Executive Officer & Director at Biodexa Pharmaceuticals Plc since 2026, Secretary & Director at Midatech Pharma (Wales) Ltd. since 2019, Secretary & Director at Biodexa Ltd. since 2019, and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Chief Executive Officer & Director at Ergomed Group Ltd. from 2018 to 2019, Chief Financial Officer & Director at Shire Plc in 1999, Chief Financial Officer & Director at Regus Group Ltd. in 2004, Director at Harefield Pharmacovigilance Ltd., CFO, CAO, SVP & Head-Investor Relations at EZCORP, Inc. from 2011 to 2012, Principal at KPMG LLP, Chief Operating & Financial Officer at Xanodyne Pharmaceuticals, Inc. in 2009, Chief Financial Officer & Senior Vice President at Assurex Health, Inc. from 2013 to 2015, Investment Banker at Lazard & Co. Holdings Ltd., and Chief Financial Officer at AMAG Pharma USA, Inc. in 2010.
Education includes undergraduate studies at The University of Manchester.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/03/2026 0 ( -.--% ) - $ 30/05/2026

Stephen Stamp active positions

CompaniesPositionStart
BIODEXA PHARMACEUTICALS PLC Chief Executive Officer 30/03/2020
Corporate Officer/Principal -
Director/Board Member 08/09/2019
Director/Board Member 08/09/2019

Former positions of Stephen Stamp

CompaniesPositionEnd
ERGOMED Chief Executive Officer 21/01/2019
Director of Finance/CFO 28/06/2015
EZCORP, INC. Director of Finance/CFO 04/10/2012
Director of Finance/CFO 31/05/2010
Director of Finance/CFO 31/12/2008
See the detail of Stephen Stamp's experience

Training of Stephen Stamp

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Finance

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!